Cor Vasa 2014, 56(2):e87-e90 | DOI: 10.1016/j.crvasa.2014.02.008

Czech preventive cardiology over the past 25 years

Hana Rosolová
Centrum preventivní kardiologie, II. interní klinika, Lékařská fakulta Plzeň, Univerzita Karlova v Praze a Fakultní nemocnice Plzeň, Plzeň, Česká republika

Published: April 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Rosolová H. Czech preventive cardiology over the past 25 years. Cor Vasa. 2014;56(2):e87-90. doi: 10.1016/j.crvasa.2014.02.008.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks, WHO, Geneva, 2009, WHO/Europe, European HFA Database. http://www.who.int/healthinfo/global_burden_disease/GlobalHealthRisks_report_full.pdf (poslední přístup červenec 2012).
    2. J. Perk, G. De Backer, H. Gohlke, et al., Task Force Members, European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). Joint ESC Guidelines, European Heart Journal 33 (2012) 1635-1701. Go to original source... Go to PubMed...
    3. Z. Reiniš, J. Pokorný, V. Bazika, et al., Epidemiologie ischemické choroby srdce u zemědělské a průmyslové populace, Thomayerova sbírka č. 476, Avicenum, Praha, 1977.
    4. J. Widimský, V. Víšek, Preventivní kardiologie, Avicenum, Praha, 1981, s. 394.
    5. H. Geizerová, Multifaktoriální primárně preventivní studie srdečních infarktů a cévních mozkových příhod. Závěrečná zpráva 1. etapy ÚSP 17-335-328-02 HE- 8/6, IKEM, Praha 1980.
    6. Z. Škodová, Multifaktoriální primárně preventivní studie srdečních infarktů a cévních mozkových příhod. Závěrečná zpráva VÚ-ZP: 17-335-452/03-4/2, IKEM, Praha 1985.
    7. Z. Škodová, Z. Píša, Z. Hejl, et al., Mezinárodní studie MONICA - první zkušenosti v ČSSR, Praktický lékař 66 (1986) 668-670.
    8. R. Cífková, Z. Škodová, J. Bruthans, et al., Longitudinal trends in major cardiovascular risk factors in the Czech population between 1985 and 2007/8. Czech MONICA and Czech post-MONICA, Atherosclerosis 211 (2010) 676-681. Go to original source... Go to PubMed...
    9. R. Cífková, Z. Škodová, J. Bruthans, et al., Longitudinal trends in cardiovascular mortality and blood pressure levels, prevalence, awareness, treatment, and control of hypertension in the Czech population from 1985 to 2007/2008, Journal of Hypertension 28 (2010) 2196-2203. Go to original source... Go to PubMed...
    10. H. Rosolová, J. Šimon, F. Šefrna, Impact of cardiovascular risk factors on morbidity and mortality in Czech middle-aged men: Pilsen Interventional Longitudinal Study (PILS), Cardiology 85 (1994) 61-68. Go to original source... Go to PubMed...
    11. H. Rosolová, L. Krejsová, J. Emmer, et al., Vliv věku a vzdělání na rizikový profil mužů a žen v průmyslové populaci (PILS II), Vnitřní lékařství 37 (1991) 678-685. Go to PubMed...
    12. J. Šimon, V. Karlíček, H.Rosolová, Závěrečná zpráva Výzkumného projektu P-12-333-810: Výzkum komplexní léčebné a preventivní péče o organizovanou (průmyslovou) populaci, Plzeň, 1990.
    13. F. Stožický, P. Slabý, L. Voleníková, Serum lipid and apolipoprotein levels in children, Česko-slovenská pediatrie 38 (11) (1983) 646-649.
    14. Z. Urbanová, M. Šamánek, R. Češka, et al., Recommendations for the diagnosis and therapy of hyperlipoproteinemia in childhood and adolescence developed by the Committee of the Czech Society for Atherosclerosis, Časopis lékařů českých 137 (3) (1998) 89-92. Go to PubMed...
    15. K. Kotseva, D. Wood, G. De Backer, et al., Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries, Lancet 373 (2009) 929-940. Go to original source... Go to PubMed...
    16. J.C. Fruchart, F.M. Sacks, M.P. Hermans, et al., The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patient, Diabetes and Vascular Disease Research 5 (2008) 319-335. Go to original source... Go to PubMed...
    17. A. Varbo, M. Benn, A. Tybjaerg-Hansen, et al., Remnant cholesterol as a causal risk factor for ischemic heart disease, Journal of the American College of Cardiology 61 (2013) 427-436. Go to original source... Go to PubMed...
    18. B.M. Sondermeijer, J.S. Rana, B.J. Arsenault, et al. Non-HDL cholesterol vs. apo B for risk of coronary heart disease in healthy individuals: the EPIC-Norfolk prospective population study, European Journal of Clinical Investigation 43 (10) (2013) 1009-1015. Go to original source... Go to PubMed...
    19. A.C. Keech, R.J. Simek, P. Barter, et al., Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial, Lancet 366 (2005) 1849-1861. Go to original source...
    20. The ACCORD Study Group and ACCORD Eye Study Group, Effects of Medical Therapies on Retinopathy Progression in Type 2 Diabetes, New England Journal of Medicine 363 (3) (2010) 233-244. Go to original source... Go to PubMed...
    21. B. Barreiro, L. Garcia, L. Lozano, et al., Obstructive sleep apnea and metabolic syndrome in Spanish population, the Open Respiratory Medicine Journal 7 (2013) 71-76. Go to original source... Go to PubMed...
    22. L. Rydén, P.J. Grant, S.D. Anker, et al., ESC guidelines on diabetes, pre-diabetes, and cadiovascular disease developed in collaboration with EASD, European Heart Journal 34 (39) (2013) 3035-3087. Go to original source...

    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes